Director shareholding

July 28, 2014 Group News
blog_img4

Esperite N.V. (Euronext: ESP, `Esperite`, or `the Group`), the leading international stem cell storage company and the largest family stem cell bank in Europe, has been informed that 242,600 ordinary shares of Euro 0.10 (`Ordinary Shares`) have been transfered to Mr Frederic Amar, Chief Executive Officer, on Friday 11 July 2014.

read more

NL – Nieuw opslag record

January 10, 2012 Group News

Bijna 40.000 nieuwe stalen opgeslagen in 2011

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘the Groep’), de toonaangevende internationale familie-stamcelbank, heeft in 2011 39.900 nieuwe stalen opgeslagen, een stijging met 4% (2010: 38.300 nieuwe stalen).

read more

Cryo-Save Group opens its doors to customers

December 7, 2011 Group News

Cryo-Save, Europe’s leading family stem cell bank, is thrilled to announce the launch of a unique program: the Board of Parents. The aim of the program is to give the opportunity to Cryo-Save’s clients, to approach the company from a new perspective and to find out more on how a family stem cell bank works in terms of laboratory procedures and cryopreservation techniques. This is a unique initiative to create interactions between the company and its customers and a way to reinforce the transparency of the organization.

read more

Cryo-Save is proud to announce the achievement of 200,000 samples stored from umbilical cord blood and umbilical cord tissue

November 22, 2011 Group News

Cryo-Save is proud to announce the storage of its 200,000th sample

This great achievement shows the successful results of Cryo-Save’s efforts in increasing the awareness of stem cell storage among the general public and the medical community. All samples stored can be considered as an outstanding source of stem cells, offering an enormous potential for treating so far incurable diseases.

read more

EN – Cryo-Save and Lazaron Biotechnologies establish stem cell bank joint venture in South Africa

June 2, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’), the leading international family stem cell bank, and John Daniel Holdings Ltd (Johannesburg Stock Exchange VCM: JDH), a venture capital company and the controlling shareholder of Lazaron Biotechnologies (SA) Ltd, Africa’s first private cord blood stem cell bank, announced today that the companies signed a memorandum of understanding to establish a new stem cell bank joint venture in South Africa.

read more

NL – Cryo-Save en Lazaron Biotechnologies starten stamcelbank joint venture in Zuid-Afrika

June 2, 2011 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’), de toonaangevende internationale familie-stamcelbank, en John Daniel Holdings Ltd (Johannesburg Stock Exchange VCM: JDH), een venture capital onderneming en de controlerend aandeelhouder van Lazaron Biotechnologies (SA) Ltd, de eerste private navelstrengbloed stamcelbank op het Afrikaanse continent, kondigden vandaag aan dat beide bedrijven een Memorandum of Understanding hebben ondertekend voor de oprichting van een nieuwe stamcelbank joint venture in Zuid- Afrika.

read more

10 years of stem cell storage

November 18, 2010 Group News

Cryo-Save celebrates 10 years of stem cell storage with increasing usage of umbilical cord stem cells

Cryo-Save Group N.V. (“Cryo-Save”) is Europe’s leading stem cell bank, and today announces the 10 year anniversary of storing the first samples of stem cells taken from umbilical cord blood in its laboratories.

read more

EN – Press release TBCCB acquisition

November 3, 2010 Group News

Acquisition of distributor

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading adult stem cell storage bank, has acquired its Bulgarian distributor, Tissue Bank Cryo Center Bulgaria AD (‘TBCCB’) for an initial consideration of €1.5 million payable in cash and 100,000 Cryo-Save Group N.V. shares, and a deferred performance payment, payable annually on the achievement of certain goals until 2013. The total acquisition price reflects approximately five times EBIT of TBCCB. The Group expects the acquisition to be earnings enhancing with immediate effect.

read more

NL – Press release TBCCB acquisition

November 3, 2010 Group News

Overname van distributeur

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, heeft zijn Bulgaarse distributeur, Tissue Bank Cryo Center Bulgaria AD (‘TBCCB’), geacquireerd. De overnameprijs bedraagt €1,5 miljoen in contanten en 100.000 aandelen Cryo-Save Group N.V. Daarnaast is gedurende drie jaar een resultaatafhankelijke betaling verschuldigd. De totale acquisitieprijs weerspiegelt ongeveer vijf maal de EBIT van TBCCB. Cryo-Save verwacht dat de acquisitie met onmiddellijke ingang bijdraagt aan de winst per aandeel.

read more

Page 1 of 212